What You Should Know:
– PhotoPharmics, a leader in specialized light therapy for neurodegenerative diseases, today announced the close of its oversubscribed $6 million Series B extension.
– The round was led by Kickstart Fund with participation from…
Continue Reading
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates genomic therapies for neurodegenerative diseases.Unlearn, founded in 2017, uses…
Continue Reading
The Critical Link Between RBD and Neurodegenerative Disease
REM sleep behavior disorder (RBD) affects over one million Americans, causing abnormal movements, twitching, and dream enactment episodes during sleep. What makes this condition particularly significant is…
Groundbreaking Research Initiative
The University of Edinburgh‘s NeurEYE research team, in collaboration with Glasgow Caledonian University, has achieved a remarkable milestone by collecting nearly one million eye scans from opticians across Scotland. This unprecedented dataset,…
Fatigue is prevalent in immune-mediated inflammatory and neurodegenerative diseases, yet its assessment relies largely on patient-reported outcomes, which capture perception but not fluctuations over time. Wearable sensors, like inertial measurement units (IMUs), offer a…
Continue Reading
South Korean medical imaging AI company Neurophet has received second clearance for its brain image analysis software in the United States.It obtained another 510(k) from the US Food and Drug Administration for the latest…
Continue Reading
Synapticure, a virtual care company for neurodegenerative diseases, has secured $25 million in Series A funding to scale its services and expand its partnerships with health systems, payers and providers, it announced Tuesday.
Chicago-based Synapticure…
Continue Reading
